knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 20:18:37 - browse：5

Illustration of a laptop on top of a TV with a hand sticking out, holding a newspaper. -- coverage from STAT — Adobe

WASHINGTON – If you live in this city, you’re probably awash in pharmacy benefit manager ads — whether you’re listening to an NPR podcast, reading the New York Times, streaming “Yellowstone,” or watching the U.S. Open Golf Championships. It doesn’t matter if it’s 5 a.m., primetime, or 11 p.m.; in between ads for dog joint supplements and the “Barbie” movie, you will inevitably learn about these middlemen of the prescription drug market.

Ads eviscerating and glorifying PBMs have been around for years. But they’ve intensified over the past three months as Congress scrutinizes PBMs’ role in shaping high drug prices. Over a half-dozen U.S. House and Senate Committees have started investigating PBMs, advancing bipartisan legislation to increase transparency in the industry; ban PBMs from charging more for a drug than what they pay (and pocketing the difference); and require them to pass all fees, rebates, and other payments they receive to insurers.

Lobbying groups have responded to this legislative push with dueling campaigns in the court of public opinion. On one side is the Pharmaceutical Care Management Association, the trade association representing PBMs, which argues that pharmaceutical companies are responsible for high drug prices. On the other side is the industry group PhRMA, which points the finger right back, saying that PBMs are really to blame. Both trade associations have launched ad campaigns worth millions of dollars, blanketing TV, radio, social media, print, and beyond.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Behind warning on Apellis’s eye drug lies a conflict of interest

WSS

Biden jokes that Republicans may impeach him because inflation is starting to cool down

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Longer MASH drug regimen improved liver, Akero study finds

Biden to sign 'historic' executive order on how US military handles sexual assault cases

He's 19 months old and has one of the world’s rarest diseases

Ending health disparities requires full federal government, panel says

explore

knowledge

knowledge

What does generative AI mean for health care? We asked experts

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Novavax promises a turnaround & Lilly roils the obesity market

Longer MASH drug regimen improved liver, Akero study finds

United colonoscopy coverage change 'may cost lives,' doctors say

Ford recalls 870K F

State Dept. review finds Biden bears some blame for Afghanistan failures

Lack of health data on LGBTQ+ people has serious consequences

As demand for Covid shots wanes, Moderna seeks its next success

Ending health disparities requires full federal government, panel says

focus

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Families look for replacement for GSK asthma drug Flovent

Medicare drug price negotiation hearing pits pharma v Biden admin

Ford recalls 870K F

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Stoke drug shows lower activity against childhood epilepsy

entertainment

explore

explore

focus